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Aldosterone is a corticosteroid hormone that plays a pivotal role in homeostatic regulation of 
water and salt reabsorption, blood volume and pressure. Aldosterone levels tent to rise in 
humans in hypertension, chronic and acute congestive heart failure (CHF); detrimental effects 
are opposed by drugs like ACE inhibitors and anti-mineralocorticoid. Aldosterone has a pulsatile 
secretion, so measurement in serum is less indicative than in urine, where concentration can be 
indexed to creatinine ratio for estimation of the 24-h aldosterone excretion. 
Few studies have evaluated aldosterone in canine urine patients, and none by ELISA. Aim of the 
study was to evaluate a commercial ELISA kit for measuring aldosterone in dog’s urine. 
Urine was collected by free catch from four dogs. Two were healthy, one was affected by CHF 
and prescribed anti-mineralocorticoid daily, one was affected by chronic kidney disease (CKD). 
Urine was centrifuged (1250g/5 min) and supernatant frozen (-20°C). Aldosterone was measured 
by a competitive ELISA previously validated for dogs. Twenty-four hours acid hydrolysis was 
performed on urinary samples before assay. 
The ELISA standard curve in a semi-log plot was linear between 2.5 and 3.9 ng/mL. Spike-and-
recovery, linearity-of-dilution and parallelism experiments showed accuracy in measuring 
aldosterone in dog urine samples (Syme et al., 2007). Concentrations of urine aldosterone are 
reported in Table 1. The intra-assay coefficient of variation showed good reproducibility of the 
assay. 
Urinary samples are easy to collect, and the ELISA used in this preliminary study seems promising 
in determining aldosterone in dog urine. Its levels can be of great diagnostic and prognostic 
value for dogs affected by acute and chronic CHF, in order to assess the best therapeutic 
strategy (Gardner et al., 2007). This preliminary analysis will be followed by further studies in 
patients affected by acute and chronic CHF. 
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PATIENT ALDOSTERONE CONCENTRATIONS (ng/mL) 
Healthy 1 2.593 ± 0.890 (CV 14.9%) 
Healthy 2 2.737 ± 0.39 (CV 14.3%) 
CHF 3.620 ± 0.44 (CV 12.2%) 
CKD 2.399 ± 0.42 (CV 17.5%) 
 
 
References 
Syme, H.M., Fletcher, M.G.R., Bailey, S.R., Elliott, J., 2007. Measurement of aldosterone in feline, canine and human 
urine. Journal of Small Animal Practice. 48, 202–208. 
Gardner S.Y., Atkins C.E., Rausch W.P., DeFrancesco, T.C., Chandler D.W., Keene B.W. 2007. Estimation of 24-h 
aldosterone secretion in the dog using the urine aldosterone: Creatinine ratio. Journal of Veterinary Cardiology 
9, 1 - 7.  
 
 
Table 1: Concentrations of urine aldosterone measured in four dogs. Values are 
mean ± SD of three determinations. In parenthesis the intra-assay coefficient of 
variation (CV%). 
